Serum cytochrome c indicates in vivo apoptosis and can serve as a prognostic marker during cancer therapy.
about
Cytochrome c as a Potentially Clinical Useful Marker of Mitochondrial and Cellular DamageLiposome-Cross-Linked Hybrid Hydrogels for Glutathione-Triggered Delivery of Multiple Cargo MoleculesSerum markers of apoptosis decrease with age and cancer stage.Intracellular zinc flux causes reactive oxygen species mediated mitochondrial dysfunction leading to cell death in Leishmania donovani.Targeting mitochondria for resuscitation from cardiac arrest.Microdevices integrating affinity columns and capillary electrophoresis for multibiomarker analysis in human serum.Assessment of circulating biomarkers for potential pharmacodynamic utility in patients with lymphoma.Elevation of serum fortilin levels is specific for apoptosis and signifies cell death in vivo.Association of circulating cytochrome c with clinical manifestations of antiretroviral-induced toxicityBrevinin-2R(1) semi-selectively kills cancer cells by a distinct mechanism, which involves the lysosomal-mitochondrial death pathwayCirculating levels of cytochrome c after resuscitation from cardiac arrest: a marker of mitochondrial injury and predictor of survival.Protecting mitochondrial bioenergetic function during resuscitation from cardiac arrest.Cerebrospinal fluid levels of high-mobility group box 1 and cytochrome C predict outcome after pediatric traumatic brain injuryAnti-DR5 mAb inhibits proliferation of human fibroblast-like synovial cells and reduces their cytokine secretion in vitro.The emerging importance of DNA mapping and other comprehensive screening techniques, as tools to identify new drug targets and as a means of (cancer) therapy personalisation.Neem oil limonoids induces p53-independent apoptosis and autophagy.Abrin P2 suppresses proliferation and induces apoptosis of colon cancer cells via mitochondrial membrane depolarization and caspase activationThe Role of M30 in Predicting the Severity of Liver Fibrosis and Inflammation in Chronic Hepatitis B PatientsSerum efficacy biomarkers for oncology.Cytochrome c: potential as a noninvasive biomarker of drug-induced acute kidney injury.Autophagy, apoptosis, mitoptosis and necrosis: interdependence between those pathways and effects on cancer.Zinc status alters growth and oxidative stress responses in rat hepatoma cells.Sodium butyrate induces human colon carcinoma HT-29 cell apoptosis through a mitochondrial pathway.Characterization of the cell death induced by cadmium in HaCaT and C6 cell lines.Adenosine and deoxyadenosine induces apoptosis in oestrogen receptor-positive and -negative human breast cancer cells via the intrinsic pathway.Diagnostic and Prognostic Utility of Circulating Cytochrome c in Acute Myocardial Infarction.Mitoptosis, a novel mitochondrial death mechanism leading predominantly to activation of autophagy.Akt isoforms differentially protect against stroke-induced neuronal injury by regulating mTOR activities.DNA damage response as a biomarker in treatment of leukemias.A high serum level of M65 is associated with tumour aggressiveness and an unfavourable prognosis for epithelial ovarian cancer.A novel strategy for tumour therapy combining cell apoptosis and active immunity induced by caspy2, a zebrafish caspase.Pancreatic response to endotoxin after chronic alcohol exposure: switch from apoptosis to necrosis?Plasma Cytochrome c Detection Using a Highly Sensitive Electrochemiluminescence Enzyme-Linked Immunosorbent Assay.Effect of tibolone and raloxifene on serum markers of apoptosis in postmenopausal women.Extracellular cytochrome c as a biomarker for monitoring therapeutic efficacy and prognosis of non-small cell lung cancer patients.An Assay Using Localized Surface Plasmon Resonance and Gold Nanorods Functionalized with Aptamers to Sense the Cytochrome-c Released from Apoptotic Cancer Cells for Anti-Cancer Drug Effect Determination
P2860
Q26739555-FB75F247-E23B-4EA9-A521-A751DF220CF3Q28829477-06A95667-6C47-4007-9A1E-5C4B135F44B3Q33588768-A0E46F76-29F5-42FF-9243-6E5DA0DCD501Q33769084-118A93CC-1641-40E6-84B9-CCB1F89D6B38Q33831890-78AF0EFF-91F3-489A-92F5-F8A61841E743Q34385535-34E743D5-86A9-46BF-981C-5E6C8F8B29DEQ34627911-05C5D3F8-7959-4E98-A48B-837FA26D3DCFQ34795048-741CC3F7-29D3-49A0-A04D-91E03E2E8BCCQ35007676-9FF63A1A-13AF-4354-80D1-5BC9208500CAQ35458516-392B0F93-3405-4C86-831F-9257CDE814DBQ35632625-41B4BB9C-DBDC-42B6-A5C9-3263DEEBCF30Q35846720-9A0E46DE-67F1-41AA-8E89-BC8B2112553DQ36127362-E19B216F-43F4-4D08-9C8F-21A21513FDC0Q36140088-79E37399-A1D7-4840-8280-40D11676ACECQ36425978-041F82E4-C9D0-4381-8574-9484D618E046Q36647000-79F71A1C-BEE9-47EF-9FD6-C94C442BF986Q36954853-D283E9D3-2C07-4804-BB30-D7B8EC734213Q37383901-C5271B74-366F-4701-B02B-D9BA1E3B5C08Q37755150-B76AC4A6-305C-4305-B6F4-982A48FE3700Q37999899-21AFEE9A-DB86-44D7-9764-E0183A81A68DQ38066407-D19E506D-190C-4309-A87F-A359345952F1Q39044806-8B04900E-8604-4948-BECE-4DAA073EB29DQ39827064-5FE93B30-E812-41EF-98AA-59A6175F60DAQ40009222-2DAEE737-E0E4-427B-9A14-B8F6867A0F5EQ40366348-92BC43EA-79F9-4DF3-8E2B-026FFD50B6BAQ40501284-96799E72-448D-4870-B4F3-86727EA6D47BQ42160305-6221AD6C-482E-4AAC-82CD-969DFB76B57DQ42276923-E49992BA-D635-41C1-ADA9-228ABAF97DCCQ42793737-15D53DC8-0768-44A5-9417-FAE9D519B92CQ43421009-DE619D44-B3BC-4BEB-B723-EAC225E8BF91Q43782686-9470F792-7F50-4095-AB57-A76C80EDA92BQ46565022-7C81A2B3-3517-409F-B4D2-4B58CB8DB740Q47094725-1658C5DE-DA87-4280-900D-56CC3FE348A4Q50941446-9DF558C3-E383-4B2A-A9BB-B39893CB3E4EQ53640484-4271FFE5-4B81-4D2E-8760-1D70BFF09CA4Q57568647-61C6A712-6EF3-4242-A95C-F7A8FBD6B18E
P2860
Serum cytochrome c indicates in vivo apoptosis and can serve as a prognostic marker during cancer therapy.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Serum cytochrome c indicates i ...... marker during cancer therapy.
@en
Serum cytochrome c indicates i ...... marker during cancer therapy.
@nl
type
label
Serum cytochrome c indicates i ...... marker during cancer therapy.
@en
Serum cytochrome c indicates i ...... marker during cancer therapy.
@nl
prefLabel
Serum cytochrome c indicates i ...... marker during cancer therapy.
@en
Serum cytochrome c indicates i ...... marker during cancer therapy.
@nl
P2093
P356
P1476
Serum cytochrome c indicates i ...... marker during cancer therapy.
@en
P2093
Evan P Booy
Johannes Roth
Juliusz Pryjma
Katarzyna Barczyk
Michael Kreuter
Saeid Ghavami
Subbareddy Maddika
Wolfgang E Berdel
P304
P356
10.1002/IJC.21037
P50
P577
2005-08-01T00:00:00Z